Literature DB >> 11727562

Antiherpetic activity of dimeric derivatives of netropsin.

V L Andronova1, S L Grokhovskii, A N Surovaya, G V Gurskii, G A Galegov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11727562     DOI： 10.1023/a:1012300527936

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  13 in total

1.  DNA binding studies and influence on the activity of DNA topoisomerases of bis-netropsins: different effects of analogs containing cis and trans ethylene linkers.

Authors:  G Burckhardt; H Simon; K Störl; H Triebel; A Walter; J W Lown; C Zimmer
Journal:  J Biomol Struct Dyn       Date:  1997-08

2.  Novel linked antiviral and antitumor agents related to netropsin and distamycin: synthesis and biological evaluation.

Authors:  J W Lown; K Krowicki; J Balzarini; R A Newman; E De Clercq
Journal:  J Med Chem       Date:  1989-10       Impact factor: 7.446

3.  Herpes simplex virus: selection of origins of DNA replication.

Authors:  O Hammarsten; P Elias
Journal:  Nucleic Acids Res       Date:  1997-05-01       Impact factor: 16.971

4.  Design of sequence-specific DNA binding ligands that use a two-stranded peptide motif for DNA sequence recognition.

Authors:  V A Nikolaev; S L Grokhovsky; A N Surovaya; T A Leinsoo; A S Zasedatelev; A L Zhuze; G A Strahan; R H Shafer; G V Gursky
Journal:  J Biomol Struct Dyn       Date:  1996-08

5.  Synthetic sequence-specific ligands.

Authors:  G V Gursky; A S Zasedatelev; A L Zhuze; A A Khorlin; S L Grokhovsky; S A Streltsov; A N Surovaya; S M Nikitin; A S Krylov; V O Retchinsky; M V Mikhailov; R S Beabealashvili; B P Gottikh
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1983

6.  Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus.

Authors:  E De Clercq; J Descamps; G Verhelst; R T Walker; A S Jones; P F Torrence; D Shugar
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

7.  [Synthesis and antiherpes activity of acyclovir phosphoesters].

Authors:  G A Galegov; V M Shobukhov; N A Leont'eva; M V Ias'ko
Journal:  Bioorg Khim       Date:  1997-11

8.  Linked lexitropsins and the in vitro inhibition of HIV-1 reverse transcriptase RNA-directed DNA polymerization: a novel induced-fit of 3,5 m-pyridyl bisdistamycin to enzyme-associated template-primer.

Authors:  M E Filipowsky; M L Kopka; M Brazil-Zison; J W Lown; R E Dickerson
Journal:  Biochemistry       Date:  1996-12-03       Impact factor: 3.162

9.  DNA sequence recognition by bis-linked netropsin and distamycin derivatives.

Authors:  S L Grokhovsky; A N Surovaya; G Burckhardt; V F Pismensky; B K Chernov; C Zimmer; G V Gursky
Journal:  FEBS Lett       Date:  1998-11-20       Impact factor: 4.124

10.  Highly potent synthetic polyamides, bisdistamycins, and lexitropsins as inhibitors of human immunodeficiency virus type 1 integrase.

Authors:  N Neamati; A Mazumder; S Sunder; J M Owen; M Tandon; J W Lown; Y Pommier
Journal:  Mol Pharmacol       Date:  1998-08       Impact factor: 4.436
View more
  3 in total

1.  Effect of dimeric derivatives of netropsin and their combinations with acyclovir on herpes simplex virus type 1 infection in mice.

Authors:  V L Andronova; S L Grokhovskii; A N Surovaya; G V Gurskii; G A Galegov
Journal:  Dokl Biochem Biophys       Date:  2007 Mar-Apr       Impact factor: 0.788

2.  Antiviral and cytotoxic activity of netropsin derivatives in vero cells infected with vaccinia virus and herpes simplex virus type I.

Authors:  V L Andronova; S L Grokhovsky; A N Surovaya; V S Arkhipova; G V Gursky; G A Galegov
Journal:  Dokl Biochem Biophys       Date:  2008 Sep-Oct       Impact factor: 0.834

3.  Complex of the herpes simplex virus type 1 origin binding protein UL9 with DNA as a platform for the design of a new type of antiviral drugs.

Authors:  N P Bazhulina; A N Surovaya; Y G Gursky; V L Andronova; E D Moiseeva; Capital A Cyrillic M Nikitin; M V Golovkin; G А Galegov; S L Grokhovsky; G V Gursky
Journal:  J Biomol Struct Dyn       Date:  2013-07-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.